The U.S. Food and Drug Administration has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). This action is a continuation of the FDA’s efforts to pursue companies that illegally market CBD products with claims that they can treat medical conditions, including opioid addiction or as an alternative to opioids.
source https://www.pharmatutor.org/pharma-news/2020/fda-warns-companies-illegally-selling-cbd-products-to-treat-medical-conditions-opioid-addiction
No comments:
Post a Comment